Dmitry Balyasny’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$462K Buy
+381,940
New +$409K ﹤0.01% 2585
2016
Q2
– Sell
-290
Closed -$97K – 1203
2016
Q1
$97K Buy
+290
New +$98.7K ﹤0.01% 1202

Other funds holding CRDF

Dmitry Balyasny's CRDF Position: Q3 2026 in Review

Dmitry Balyasny opened a new position in Cardiff Oncology (CRDF) in Q3 2026: 381,940 shares worth $462K. The stake represents ﹤0.01% of the portfolio and ranks #2585 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in CRDF as recently as Q1 2016.

Dmitry Balyasny first reported a position in CRDF in Q1 2016 and has held it in 2 quarters since. 75 funds tracked by Wall St. Rank hold CRDF as of Q3 2026.

  • Dmitry Balyasny held 381,940 shares of Cardiff Oncology worth $462K as of Q3 2026.
  • Cardiff Oncology was a new Dmitry Balyasny position in Q3 2026.
  • Cardiff Oncology made up ﹤0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #2585 holding.
  • Dmitry Balyasny first reported a position in Cardiff Oncology in Q1 2016 and has held it in 2 quarters since.
  • 75 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.